Xiamen Innovax Biotech Co., Ltd
Xiamen Innovax Biotech Co., Ltd
Explore linked clinical trials.8 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Lot-to-Lot Consistency Clinical Trial of Recombinant Human Papillomavirus 9-valent (Types 6/11/16/18/31/33/45/52/58) Vaccine (Escherichia Coli) | Infection by Human Papilloma Virus | Recruiting | Phase 4 | 2026-06-25 | NCT07668271 | |
| Effectiveness of Large Language Model-Based Chatbot Among Parents of Junior High School Girls in Improving Human Papillomavirus (HPV) Vaccine Awareness, Intention and Vaccination Rates | HPV Vaccination Intention; HPV Vaccination Rates; HPV Vaccine Awareness | Not yet recruiting | Not applicable | 2026-04-15 | NCT07525245 | |
| Efficacy, Immunogenicity and Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli) | DNA Virus Infections, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Infections, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin Diseases, Viral, Skin and Connective Tissue Diseases, Tumor Virus Infections, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, anogenital human papillomavirus infection, cervix disorder, common wart, dysplasia of cervix, female reproductive system disorder, female reproductive system neoplasm, human papilloma virus infection, infectious disease, neoplasm, precancerous condition, sexually transmitted disease, skin disorder, skin disorder caused by infection, uterine disorder, viral infectious disease, viral sexually transmitted disease | Active, not recruiting | Phase 3 | 2025-11-21 | NCT04537156 | |
| A Phase III Trial to Evaluate the Efficacy, Immunogenicity and Safety of a Recombinant Human Papillomavirus 9-Valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine (E.Coli) in Chinese Males | Anal Cancer, DNA Virus Infections, Digestive System Diseases, Digestive System Neoplasms, Disease Attributes, Genital Diseases, Infections, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin Diseases, Viral, Skin and Connective Tissue Diseases, Tumor Virus Infections, Urogenital Diseases, anogenital human papillomavirus infection, anus disorder, anus neoplasm, colorectal neoplasm, common wart, digestive system disorder, digestive system neoplasm, human papilloma virus infection, infectious disease, intestinal disorder, neoplasm, rectal disorder, rectal neoplasm, sexually transmitted disease, skin disorder, skin disorder caused by infection, viral infectious disease, viral sexually transmitted disease | Active, not recruiting | Phase 3 | 2025-07-31 | NCT06866574 | |
| Long-term Effectiveness and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Preadolescent Girls | Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Infections, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Persistent Infection, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, cervix disorder, dysplasia of cervix, female reproductive system disorder, female reproductive system neoplasm, neoplasm, precancerous condition, uterine disorder | Active, not recruiting | Not stated | 2025-07-31 | NCT06243666 | |
| Plateau Antibody Levels of a Recombinant (E.Coli) HPV Nonavalent Vaccine Versus Gardasil®9 in Young Women | DNA Virus Infections, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Infections, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin Diseases, Viral, Skin and Connective Tissue Diseases, Tumor Virus Infections, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, anogenital human papillomavirus infection, cervix disorder, common wart, female reproductive system disorder, female reproductive system neoplasm, human papilloma virus infection, infectious disease, neoplasm, sexually transmitted disease, skin disorder, skin disorder caused by infection, uterine disorder, viral infectious disease, viral sexually transmitted disease | Active, not recruiting | Not stated | 2025-07-31 | NCT06197802 | |
| An Immuno-bridging Study of a Nonavalent HPV Vaccine (E.Coli) in Healthy Population Aged 9-17 vs Aged 18-26 Years Old | DNA Virus Infections, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Infections, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin Diseases, Viral, Skin and Connective Tissue Diseases, Tumor Virus Infections, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, anogenital human papillomavirus infection, cervix disorder, common wart, female reproductive system disorder, female reproductive system neoplasm, human papilloma virus infection, infectious disease, neoplasm, sexually transmitted disease, skin disorder, skin disorder caused by infection, uterine disorder, viral infectious disease, viral sexually transmitted disease | Active, not recruiting | Phase 3 | 2025-07-22 | NCT05056402 | |
| Immunogenicity and Safety of Hecolin® in HIV Positive/Negative Adults and in Children | Digestive System Diseases, Infections, RNA Virus Infections, hepatitis, hepatitis E virus infection, liver disorder, viral hepatitis, viral infectious disease | Recruiting | Phase 2 | 2025-04-29 | NCT06306196 |